A Randomized Trial of Dolutegravir Plus Darunavir/Cobicistat as a Switch Strategy in HIV-1-Infected Patients With Resistance to at Least 2 Antiretroviral Classes

BACKGROUND: Suppressed patients with drug-resistant HIV-1 require effective and simple antiretroviral therapy to maintain treatment adherence and viral suppression. METHODS: This randomized, open-label, noninferiority, multicenter pilot study involved HIV-infected adults who met the following criter...

Descripción completa

Detalles Bibliográficos
Autores principales: Santos, José R, Domingo, Pere, Portilla, Joaquín, Gutiérrez, Félix, Imaz, Arkaitz, Vilchez, Helem, Curran, Adrià, Valcarce-Pardeiro, Nieves, Payeras, Antoni, Bernal, Enrique, Montero-Alonso, Marta, Yzusqui, Miguel, Clotet, Bonaventura, Videla, Sebastià, Moltó, José, Paredes, Roger
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10661076/
https://www.ncbi.nlm.nih.gov/pubmed/38023553
http://dx.doi.org/10.1093/ofid/ofad542

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10661076/
https://www.ncbi.nlm.nih.gov/pubmed/38023553
http://dx.doi.org/10.1093/ofid/ofad542

Ejemplares similares